CT110 Antibodies
We offer CT110 Antibodies for use in common research applications: ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot. Each CT110 Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our CT110 Antibodies can be used in a variety of model species: Human. Use the list below to choose the CT110 Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our CT110 polyclonal antibodies.
Alternate Names for CT110 Antibodies
anti-CT110 antibody, anti-GPATCH2 antibody, anti-cancer/testis antigen 110 antibody, anti-FLJ10252 antibody, anti-FLJ21048 antibody, anti-G patch domain containing 2 antibody, anti-G patch domain-containing protein 2 antibody, anti-GPATC2 antibody, anti-MGC74998 antibody, anti-RP11-361K17.1 antibody
7 Results for "ct110" in Primary Antibodies
![Western Blot: CT110 Antibody [NBP1-88045] - Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11. Lane 2: Human cell line RT-138](http://images.novusbio.com/fullsize/CT110-Antibody-Western-Blot-NBP1-88045-img0006.jpg "Western Blot: CT110 Antibody [NBP1-88045] - Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11. Lane 2: Human cell line RT-138")
![Immunohistochemistry-Paraffin: CT110 Antibody [NBP1-88045] - Staining of human testis shows nuclear positivity in cells in seminiferous ducts and Leydig cells.](http://images.novusbio.com/fullsize/CT110-Antibody-Immunohistochemistry-Paraffin-NBP1-88045-img0007.jpg)
![Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/nbp1-88045_rabbit-polyclonal-ct110-antibody-65202516215415.jpg)
![Immunohistochemistry-Paraffin: CT110 Antibody [NBP1-88046] - Staining of human testis shows cytoplasmic positivity in cells in seminiferous ducts and Leydig cells.](http://images.novusbio.com/fullsize/CT110-Antibody-Immunohistochemistry-Paraffin-NBP1-88046-img0003.jpg "Immunohistochemistry-Paraffin: CT110 Antibody [NBP1-88046] - Staining of human testis shows cytoplasmic positivity in cells in seminiferous ducts and Leydig cells.")
![Western Blot: CT110 Antibody [NBP2-87225] - Host: Rabbit. Target Name: GPATCH2. Sample Tissue: Human Ovary Tumor lysates. Antibody Dilution: 1ug/ml](http://images.novusbio.com/fullsize/CT110-Antibody-Western-Blot-NBP2-87225-img0001.jpg "Western Blot: CT110 Antibody [NBP2-87225] - Host: Rabbit. Target Name: GPATCH2. Sample Tissue: Human Ovary Tumor lysates. Antibody Dilution: 1ug/ml")
![Western Blot: CT110 Antibody [NBP3-10638] - Western blot analysis of CT110 in Rat Spleen lysates. Antibody dilution at 1.0ug/ml](http://images.novusbio.com/fullsize/CT110-Antibody-Western-Blot-NBP3-10638-img0001.jpg "Western Blot: CT110 Antibody [NBP3-10638] - Western blot analysis of CT110 in Rat Spleen lysates. Antibody dilution at 1.0ug/ml")
![Western Blot: CT110 Antibody [NBP2-87224] - Host: Rabbit. Target Name: Gpatch2. Sample Type: Mouse Spleen lysates. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/CT110-Antibody-Western-Blot-NBP2-87224-img0001.jpg "Western Blot: CT110 Antibody [NBP2-87224] - Host: Rabbit. Target Name: Gpatch2. Sample Type: Mouse Spleen lysates. Antibody Dilution: 1.0ug/ml")
![Western Blot: CT110 Antibody [NBP2-99286] - Anti-CT110 rabbit polyclonal antibody at 1:500 dilution. Lane A: Mouse spleen tissue Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 58 kDa. Observed band size: 58 kDa](http://images.novusbio.com/fullsize/CT110-Antibody-Western-Blot-NBP2-99286-img0002.jpg "Western Blot: CT110 Antibody [NBP2-99286] - Anti-CT110 rabbit polyclonal antibody at 1:500 dilution. Lane A: Mouse spleen tissue Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 58 kDa. Observed band size: 58 kDa")